Table 1 Characteristics of study participants assessed for willingness to take an opioid antagonist (N = 657)
From: Factors associated with willingness to take extended release naltrexone among injection drug users
Characteristic | Willingness | Odds ratio (95% CI £ ) | p value | |
|---|---|---|---|---|
No = 315 (%) | Yes = 342 (%) | |||
Age [Median, (IQR ¥ )] | 49 (41–54) | 46 (40–51) | 0.98 (0.96–1.00) | 0.015 |
Gender | ||||
Male | 209 (66.3) | 199 (58.2) | ||
Female | 106 (33.7) | 143 (41.8) | 1.42 (1.03–1.95) | 0.032 |
Caucasian ethnicity | ||||
No | 102 (32.4) | 158 (46.2) | ||
Yes | 213 (67.6) | 184 (53.8) | 0.56 (0.41–0.77) | < 0.001 |
Daily heroin injection* | ||||
No | 268 (85.1) | 270 (79.0) | ||
Yes | 47 (14.9) | 71 (20.8) | 1.50 (1.00–2.25) | 0.050 |
Daily cocaine injection* | ||||
No | 289 (91.7) | 319 (93.3) | ||
Yes | 26 (8.3) | 23 (6.7) | 0.80 (0.45–1.44) | 0.457 |
Daily crack smoking* | ||||
No | 251 (79.7) | 279 (81.6) | ||
Yes | 64 (20.3) | 63 (18.4) | 0.89 (0.60–1.30) | 0.538 |
Homelessness* | ||||
No | 273 (86.7) | 295 (86.3) | ||
Yes | 42 (13.3) | 46 (13.5) | 1.01 (0.65–1.59) | 0.953 |
Sex work* | ||||
No | 293 (93.0) | 312 (91.2) | ||
Yes | 22 (7.0) | 30 (8.8) | 1.28 (0.72–2.27) | 0.397 |
HIV positive | ||||
No | 189 (60.0) | 198 (57.9) | ||
Yes | 126 (40.0) | 144 (42.1) | 1.09 (0.80–1.49) | 0.584 |
Participation in drug treatment** | ||||
No | 257 (81.6) | 275 (80.4) | ||
Yes | 57 (18.1) | 64 (18.7) | 1.05 (0.71–1.56) | 0.812 |